US Department of Defense: Amyotrophic Lateral Sclerosis Research Programme (Therapeutic Development & Therapeutic Idea Awards)

The US Department of Defense, under its amyotrophic lateral sclerosis research programme, invites pre-applications for the following awards.

Therapeutic Development Award

This supports research ranging from validation of therapeutic leads through investigational new drug-enabling studies. Studies are expected to be empirical in nature and product-driven. Applications must include preliminary data.

  • Funding: Up to USD $1.25M (approx. AUD $1.73M)
  • Duration: Up to two years.
  • Eligibility: Independent investigators at all academic levels may apply. Applicants with limited ALS experience are strongly encouraged to collaborate with those having substantial expertise in ALS research or ALS model systems.
  • Visit the website for this scheme

Therapeutic Idea Award

This supports new ideas aimed at drug or treatment discovery for amyotrophic lateral sclerosis that are still in the early stages of development. Development or modification of preclinical model systems or the application of high-throughput screens to define or assess lead compounds for ALS treatment are of interest. Development of methods to adequately measure target binding and proximal downstream effects and the potential for undesirable activities at related but unintended targets are also encouraged.

  • Funding: Up to USD $500,000 (approx. AUD $690,000)
  • Duration: Up to two years
  • Eligibility: Independent investigators at all academic levels may apply. Collaborations with established ALS researchers are encouraged.
  • Visit the website for this scheme

Submission Requirements & Due Dates

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.